KLK10 provided the best example of subgroup-specificity, being hypermethylated in 48% of Lynch syndrome-colorectal cancers compared to 8% for sporadic MSI and 12% for sporadic MSS colorectal cancers. Here, KLK10 is linked to colorectal cancer.